First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran
Iran's new H. pylori treatment guidelines match local drug resistance patterns and expert evidence, aiming to prevent more stomach cancers.
Iran's first national H. pylori consensus guideline, developed through GRADE methodology with a multidisciplinary expert panel, provides 35 evidence-graded recommendations tailored to local epidemiology including high clarithromycin resistance. By prioritizing bismuth quadruple therapy and integrating local resistance patterns, the guideline aims to improve eradication rates, antibiotic stewardship, and gastric cancer prevention in a high-burden country.
What the study was
- Study design
- Multidisciplinary consensus guideline (GRADE framework, 12 structured meetings, national conference, ≥80% agreement threshold)
- Population
- Adults with H. pylori infection in Iran; high-prevalence, high-gastric cancer burden, high clarithromycin resistance (>20%) setting
- Category
- Prevention
- Maturity
- Validated
- Journal
- Helicobacter
Why it surfaced
First national Iranian guideline for a very high-burden infection (50-80% prevalence in Iran); directly implementable for Iran/high-resistance regions. Gastric cancer prevention angle relevant to watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.